Prof. George Obeng Adjei, FGA, Professor of Paediatric Clinical Pharmacology at University of Ghana Medical School, and Director, Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana has called for the establishment of a National Precision Medicine Network to improve the treatment of patients with multiple chronic conditions in Ghana. He made the call on Thursday, 1st October 2026, while delivering his inaugural Lecture at the Ghana Academy of Arts and Sciences (GAAS) Secretariat in Accra.
Speaking on the theme, “Precision Medicine or Evidence Based Medicine: Addressing Multimorbidity in Ghana,” Prof. Obeng Adjei stressed the need for Ghana to strengthen its healthcare approach to reflect the different needs and circumstances of individual patients. He advocated stronger collaboration among hospitals and research institutions, improved health information systems, and increased investment in research to advance personalised, patient centred healthcare.
Multimorbidity, he explained, refers to the presence of two or more chronic conditions in the same person. It can result in poorer health outcomes, reduced quality of life, increased hospital admissions and higher healthcare costs. He noted that multimorbidity is increasing in Ghana and that managing multimorbidity presents a significant challenge because most clinical guidelines and clinical trials – pillars upon which evidence-based medicine is based, often references a single-disease framework.
Prof. Obeng Adjei emphasised that evidence-based medicine remained essential to healthcare but needed to be complemented by approaches that accounted for individual differences in genetics, lifestyle, environment and medical history.
EBM must therefore evolve from “evidence for diseases” to “evidence for patients with multiple diseases.
“The right dose for one person may be the wrong dose for another,” he noted, explaining that genetic variations can influence how individuals respond to the same medication.
He further observed that despite Africa’s considerable genetic diversity, African populations remain underrepresented in global genomic datasets. This limits the extent to which findings from other populations can be applied directly to African patients, underscoring the need for greater investment in research that reflects the genetic diversity of African populations.
Assessing Ghana’s research capacity, Prof. Adjei acknowledged the country’s existing strengths in clinical research, drug regulation and research ethics. However, he identified gaps in early-stage discovery, translational research and locally funded clinical development as areas requiring greater investment and attention.
He called for development of capacity and increased investment in pharmacogenomics, data science and mainstreaming multimorbidity in clinical specialist training, alongside stronger collaboration among healthcare institutions and researchers. He also underscored the need for secure, interoperable health information systems that would enable existing digital platforms to exchange information effectively. Such systems, he explained, could connect hospitals, research institutions, patient records and disease registries to support safer and more effective treatment decisions.
On healthcare delivery, Prof. Adjei advocated integrating multimorbidity management into primary healthcare to ensure that patients with multiple chronic conditions received coordinated care beyond specialist and tertiary hospitals. He also highlighted the importance of adopting a more innovative approach to developing clinical pharmacology and clinical bioinformatics as distinct specialties to support the advancement of precision medicine in Ghana.
Prof. Obeng Adjei, who is also the Honorary Secretary, GAAS, stressed that advancing precision medicine should not mean abandoning evidence-based medicine in favour of precision medicine. Rather, the two approaches should complement each other towards evidence-informed, patient-centred and precision-enabled medicine to ensure the best available scientific evidence is applied to the needs of individual patients.
Chairing the lecture, Emerita Prof. Isabella Akyinbah Quakyi, FGA, President of GAAS, commended Prof. Adjei for his thought-provoking lecture and emphasised the need for Ghana to move from disease specific treatment towards patient centred care that considers the combination of conditions affecting each individual.
She also called for stronger collaboration among academic institutions, researchers and healthcare professionals to build local research capacity and develop the expertise needed to advance precision medicine.
The lecture attracted a distinguished audience comprising past Presidents and Fellows of the Academy, policymakers, healthcare stakeholders, students from Accra Academy Senior High School, Accra Girls Senior High School and Labone Senior High School, traditional leaders including chiefs and elders from Larteh-Akuapem, as well as members of the general public.
The GAAS Inaugural Lecture Series is one of the Academy’s flagship academic programmes. It provides a platform for Fellows to share research, stimulate national discourse and contribute to policy development on issues of national importance.

